Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

RNA — Atrium Therapeutics, Inc.

N/A · Quality 11/100

RNA - Atrium Therapeutics, Inc.
Data generated 2026-09-19 21:53 UTC (nightly scan, universe: Russell 3000).
Price: 8.95 USD
Valuation: N/A
Value Score: 14.5
Quality: 11/100
Moat score: 8.3 (erosion: none)
N/A - Quality 11/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/RNA
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

8.95

Intrinsic value

Margin of safety

Implied growth (reverse DCF)

a described calculation from stated inputs, not a forecast

Value Score

14.5

Quality

Psychology

38.7

Discovery

56.5

price/volume attention only

Moat score

8.3

erosion: none

Value Score: bottom 21% of Russell 3000 · Quality: bottom 7%

Open the interactive Deep Dive for RNA →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/RNA - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

What is Atrium Therapeutics, Inc.'s Value Score?

Atrium Therapeutics, Inc.'s Value Score is 14.5 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.